<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="but closely resembles SARS CoV‐1, which was responsible for the" exact="severe acute respiratory syndrome" post="(SARS) outbreak in 2002. SARS CoV‐1 and 2 share"/>
 <result pre="he noticed a series of patients showing signs of a" exact="severe acute respiratory syndrome" post="or SARS‐like illness which was subsequently reported to the"/>
 <result pre="all emerging infectious diseases.1 Geographic hotspots, or maps reflecting zoonotic" exact="infectious disease" post="risk have been identified in South American, Africa and"/>
 <result pre="to SARS‐CoV‐1.8 SARS‐CoV‐2 is more closely related to two bat‐derived" exact="severe acute respiratory syndrome" post="(SARS)‐like coronaviruses, bat‐SL‐CoVZC45 and bat‐SL‐CoVZXC21, collected in 2018 in"/>
 <result pre="efficacy.26 Animal models demonstrated an analogous effect. Prior immunization with" exact="severe acute respiratory syndrome" post="(SARS)‐associated coronavirus (SARS‐Cove) nucleocapsid protein caused severe pneumonia in"/>
 <result pre="acute respiratory syndrome (SARS)‐associated coronavirus (SARS‐Cove) nucleocapsid protein caused severe" exact="pneumonia" post="in mice infected with SARS‐CoV.27 Demonstrations of safety and"/>
 <result pre="AllenJ. Infection control for the otolaryngologist in the era of" exact="severe acute respiratory syndrome." post="J Otolaryngol. 2003;32(5):281‐287.14974856 8ZhouP, YangXL, WangXG, et al. A"/>
 <result pre="syndrome. J Otolaryngol. 2003;32(5):281‐287.14974856 8ZhouP, YangXL, WangXG, et al. A" exact="pneumonia" post="outbreak associated with a new coronavirus of probable bat"/>
 <result pre="10LiJY, YouZ, WangQ, et al. The epidemic of 2019‐novel‐coronavirus (2019‐nCoV)" exact="pneumonia" post="and insights for emerging infectious diseases in the future."/>
 <result pre="cross‐neutralizing human monoclonal antibody protection against lethal human and zoonotic" exact="severe acute respiratory syndrome" post="coronavirus challenge. J Virol. 2008;82(7):3220‐3235.18199635 17PetherickA. Developing antibody tests"/>
 <result pre="Safety and immunogenicity from a phase I trial of inactivated" exact="severe acute respiratory syndrome" post="coronavirus vaccine. Antivir Ther. 2007;12(7):1107‐1113.18018769 25LurieN, SavilleM, HatchettR, HaltonJ."/>
 <result pre="Immunol. 2003;16(1):69‐86.12725690 27YasuiF, KaiC, KitabatakeM, et al. Prior immunization with" exact="severe acute respiratory syndrome" post="(SARS)‐associated coronavirus (SARS‐CoV) nucleocapsid protein causes severe pneumonia in"/>
 <result pre="acute respiratory syndrome (SARS)‐associated coronavirus (SARS‐CoV) nucleocapsid protein causes severe" exact="pneumonia" post="in mice infected with SARS‐CoV. J Immunol. 2008;181(9):6337‐6348.18941225 28MitsukiYY,"/>
 <result pre="antibody neutralization affects in vitro and in vivo fitness of" exact="severe acute respiratory syndrome" post="coronavirus. J Infect Dis. 2010;201(6):946–955. 20144042 30ter MeulenJ, van"/>
 <result pre="PLoS Med. 2006;3(7):e23716796401 31CoughlinMM, PrabhakarBS. Neutralizing human monoclonal antibodies to" exact="severe acute respiratory syndrome" post="coronavirus: target, mechanism of action, and therapeutic potential. Rev"/>
</results>
